ArticleOpen forum infectious diseases2018
Using Patient Risk Factors to Identify Whether Carbapenem-Resistant
Article in Open forum infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 16 citations in OpenAlex.
- Faecal carriage of extended-spectrum beta-lactamase and carbapenemase-producing enterobacterales among HIV patients at Jimma Medical Center, Southwest Ethiopia.BMC microbiology · 2024Article
- Carbapenem-resistantOpen forum infectious diseases · 2024Article
- Multicentre genetic diversity study of carbapenem-resistant Enterobacterales: predominance of untypeable pUVA-likeJAC-antimicrobial resistance · 2023Article
- Combination antibiotic therapy for treatment of a patient with infected prosthesis and peri-prosthetic abscess due toIDCases · 2022Article
- Increased carbapenemase testing following implementation of national VA guidelines for carbapenem-resistant Enterobacterales (CRE).Antimicrobial stewardship & healthcare epidemiology : ASHE · 2022Article
- Multicentre study of the main carbapenem resistance mechanisms in important members of theNew microbes and new infections · 2021Article
- Frequency of and risk factors for carbapenem-resistantJournal of medical microbiology · 2021Article
- Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.Antimicrobial agents and chemotherapy · 2019Article
- Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.Infection control and hospital epidemiology · 2019Observational
- Carbapenem-ResistantBioMed research international · 2019Article
- How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications?Infection control and hospital epidemiology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
Abstract
Evaluating all inpatient carbapenem-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.